CoChat
Sign Up
Cited by 14

The DOI matches its Crossref record.

Epidemiology, Microbiology, and Clinical Outcomes Among Patients With Intravenous Drug Use-Associated Infective Endocarditis in New Brunswick

Mosseler, Kimiko, Materniak, Stefanie, Brothers, Thomas D., Webster, Duncan·2020·CJC Open
DOI 10.1016/j.cjco.2020.05.002PMC PMC7499377
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cjco.2020.05.002

Cites

Statistics

Figures

Figure 1 Number of cases of IVDU-IE by the New Brunswick geographic region per year (left Y axis) and incidence of IVDU-IE for southern New Brunswick (Saint John area, Health Region 2) per 100,000 population (right Y axis). IVDU-IE, intravenous drug use–associated infective endocarditis.
Figure 1 Number of cases of IVDU-IE by the New Brunswick geographic region per year (left Y axis) and incidence of IVDU-IE for southern New Brunswick (Saint John area, Health Region 2) per 100,000 population (right Y axis). IVDU-IE, intravenous drug use–associated infective endocarditis.CC BY-NC-ND · PubMed Central
Figure 2 Survival (all-cause mortality) after hospital admission for the first episode of IVDU-IE during the study period. IVDU-IE, intravenous drug use–associated infective endocarditis.
Figure 2 Survival (all-cause mortality) after hospital admission for the first episode of IVDU-IE during the study period. IVDU-IE, intravenous drug use–associated infective endocarditis.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 37

  1. Roy, 2016, Epidemiology of injection drug use, Can J Psychiatry, 61, 136, 10.1177/0706743716632503 · DOI
  2. Jacka, 2019, Prevalence of injecting drug use and coverage of interventions to prevent HIV and hepatitis C virus infection among people who inject drugs in Canada, Am J Public Health, 14, e1
  3. Thuny, 2014, Infective endocarditis: prevention, diagnosis, and management, Can J Cardiol, 30, 1046
  4. Mostaghim, 2017, A retrospective epidemiologic study to define risk factors, microbiology, and clinical outcomes of infective endocarditis in a large tertiary-care teaching hospital, SAGE Open Med, 5, 10.1177/2050312117741772 · DOI
  5. Hartman, 2016, Opiate injection-associated infective endocarditis in the southeastern United States, Am J Med Sci, 352, 603, 10.1016/j.amjms.2016.08.010 · DOI
  6. Coverdale, 2019, Rates of infective endocarditis in substance use disorder and associated costs in Ontario, Can J Addict, 10, 36, 10.1097/CXA.0000000000000053 · DOI
  7. Weir, 2019, The risk of infective endocarditis among people who inject drugs: a retrospective, population-based time series analysis, CMAJ, 191, E93, 10.1503/cmaj.180694 · DOI
  8. Schranz, 2019, Trends in drug use–associated infective endocarditis and heart valve surgery, 2007 to 2017: a study of statewide discharge data, Ann Intern Med, 170, 31, 10.7326/M18-2124 · DOI
  9. Gray, 2018, Rising rates of injection drug use associated infective endocarditis in Virginia with missed opportunities for addiction treatment referral: a retrospective cohort study, BMC Infect Dis, 18, 532, 10.1186/s12879-018-3408-y · DOI
  10. Martin, 2018, Trends in infective endocarditis during the substance use disorder epidemic at an academic medical center, Open Forum Infect Dis, 5, S306, 10.1093/ofid/ofy210.863 · DOI
  11. Wurcel, 2016, Increasing infectious endocarditis admissions among young people who inject drugs, Open Forum Infect Dis, 3, ofw157, 10.1093/ofid/ofw157 · DOI
  12. Kadri, 2019, Geographic trends, patient characteristics, and outcomes of infective endocarditis associated with drug abuse in the United States from 2002 to 2016, J Am Heart Assoc, 8
  13. Rudasill, 2019, Clinical outcomes of infective endocarditis in injection drug users, J Am Coll Cardiol, 73, 559, 10.1016/j.jacc.2018.10.082 · DOI
  14. Deo, 2018, Admissions for infective endocarditis in intravenous drug users, J Am Coll Cardiol, 71, 1596, 10.1016/j.jacc.2018.02.011 · DOI
  15. Lewer, 2017, Opiate injection-associated skin, soft tissue, and vascular infections, England, UK, 1997-2016, Emerg Infect Dis, 23, 1400, 10.3201/eid2308.170439 · DOI · Paper page
  16. Colville, 2016, Infective endocarditis in intravenous drug users: a review article, Postgrad Med J, 92, 105, 10.1136/postgradmedj-2015-133648 · DOI
  17. Wurcel, 2020, Impact of substance use disorder on midterm mortality after valve surgery for endocarditis, Ann Thorac Surg, 109, 1426, 10.1016/j.athoracsur.2019.09.004 · DOI
  18. Kim, 2016, Surgical outcomes of infective endocarditis among intravenous drug users, J Thorac Cardiovasc Surg, 152, 832, 10.1016/j.jtcvs.2016.02.072 · DOI
  19. Lemaire, 2017, Patients with infectious endocarditis and drug dependence have worse clinical outcomes after valvular surgery, Surg Infect, 18, 299, 10.1089/sur.2016.029 · DOI
  20. Li, 2000, Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis, Clin Infect Dis, 30, 633, 10.1086/313753 · DOI · Paper page
  21. Rosenthal, 2016, Suboptimal addiction interventions for patients hospitalized with injection drug use-associated infective endocarditis, Am J Med, 129, 481, 10.1016/j.amjmed.2015.09.024 · DOI · Paper page
  22. Hussey, 1950, Infections resulting from narcotic addiction: report of 102 cases, Am J Med, 9, 186, 10.1016/0002-9343(50)90021-0 · DOI
  23. Brown, 2002, Infective endocarditis in the injection drug user, Infect Dis Clin North Am, 16, 645, 10.1016/S0891-5520(02)00019-3 · DOI
  24. Trifunovic, 2018, The relationship between causative microorganisms and cardiac lesions caused by infective endocarditis: new perspectives from the contemporary cohort of patients, J Cardiol, 71, 291
  25. Kasper, 2019, A controlled-release oral opioid supports S. aureus survival in injection drug preparation equipment and may increase bacteremia and endocarditis risk, PLoS One, 14
  26. Mateu-Gelabert, 2018, The opioid epidemic and injection drug use: MIPIE and health harms related to the injection of prescription opioids, Int J Drug Policy, 57, 130, 10.1016/j.drugpo.2018.03.019 · DOI
  27. Roy, 2011, The growing popularity of prescription opioid injection in Downtown Montréal: new challenges for harm reduction, Subst Use Misuse, 46, 1142, 10.3109/10826084.2011.552932 · DOI
  28. Wurcel, 2019, Drug-associated infective endocarditis trends: what’s all the buzz about?, Ann Intern Med, 170, 68, 10.7326/M18-3026 · DOI
  29. Lambdin, 2019, Associations between perceived illicit fentanyl use and infectious disease risks among people who inject drugs, Int J Drug Policy, 74, 299, 10.1016/j.drugpo.2019.10.004 · DOI
  30. Kaura, 2017, Inception of the ‘endocarditis team’ is associated with improved survival in patients with infective endocarditis who are managed medically: findings from a before-and-after study, Open Heart, 4, 10.1136/openhrt-2017-000699 · DOI
  31. Brothers TD, Webster D. Multidisciplinary infective endocarditis care teams should address substance use disorders and harm reduction services [e-pub ahead of print]. Open Heart. Available at: https://openheart.bmj.com/content/4/2/e000699.responses#multidisciplinary-infective-endocarditis-care-teams-should-address-substance-use-disorders-and-harm-reduction-services.
  32. Marks, 2019, Addiction medicine consultations reduce readmission rates for patients with serious infections from opioid use disorder, Clin Infect Dis, 68, 1935, 10.1093/cid/ciy924 · DOI
  33. Rodger, 2018, Clinical characteristics and factors associated with mortality in first-episode infective endocarditis among persons who inject drugs, JAMA Netw Open, 1, 10.1001/jamanetworkopen.2018.5220 · DOI
  34. Alagna, 2014, Repeat endocarditis: analysis of risk factors based on the International Collaboration on Endocarditis – Prospective Cohort Study, Clin Microbiol Infect, 20, 566, 10.1111/1469-0691.12395 · DOI
  35. Pierce, 2012, Infectious endocarditis: diagnosis and treatment, Am Fam Physician, 85, 6
  36. Østerdal, 2016, Cardiac surgery for infective endocarditis in patients with intravenous drug use, Interact Cardiovasc Thorac Surg, 22, 633, 10.1093/icvts/ivv397 · DOI
  37. Buchanan, 2019, Making the cut: perspectives on the surgical management of infective endocarditis among people who use intravenous drugs, Can J Cardiol, 35, 1416

Cited by

Sorted by citations

See all 14

Metadata

Authors
Mosseler, K., Materniak, S., Brothers, T. D., & Webster, D.
ORCID
Venue
CJC Open
Publisher
Elsevier BV
Published
2020-09
Volume
2
Issue
5
Pages
379-385
ISSN
2589-790X
DOI
10.1016/j.cjco.2020.05.002
PMC
PMC7499377
Cited by
14
References
0
Language
en
Licence
Funders
Dalhousie Medical Research Foundation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Epidemiology, Microbiology, and Clinical Outcomes Among Patients With Intravenous Drug Use-Associated Infective Endocarditis in New Brunswick. https://app.cochat.ai/papers/10.1016/j.cjco.2020.05.002
The paper
Mosseler, K., Materniak, S., Brothers, T. D., & Webster, D. (2020). Epidemiology, Microbiology, and Clinical Outcomes Among Patients With Intravenous Drug Use-Associated Infective Endocarditis in New Brunswick. CJC Open. https://doi.org/10.1016/j.cjco.2020.05.002